Skip to main content
. 2006 Sep;22(11):935–937. doi: 10.1016/s0828-282x(06)70312-9

TABLE 3.

Medical treatment by group (diabetic versus nondiabetic patients

Diabetic (n=281), n (%) Nondiabetic (n=733), n (%) P
Acetylsalicylic acid 186 (66.2) 443 (60.4) NS
Beta-blocker 164 (58.3) 387 (52.7) NS
ACEI 208 (74.0) 497 (67.8) NS
Statin 213 (75.8) 543 (74.0) NS

ACEI Angiotensin-converting enzyme inhibitor; NS Not significant